Awards as PI
| Funding | ||
|---|---|---|
| Disease Team Therapy Planning I | Combination therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy | $86,414 |
| Early Translational from Disease Team Conversion | Combination therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy | $6,000,000 |
Total: $6,086,414.00 |
